|
Market Closed -
Bombay S.E.
11:02:19 20/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 518.10 INR | +1.25% |
|
-4.44% | +17.39% |
| Market Cap | 36.48B 381M 326M 305M 279M 525M 535M 3.61B 1.41B 18.28B 1.43B 1.4B 60.52B | P/E 2025 |
35.6x | P/E 2026 | 8.19x |
|---|---|---|---|---|---|
| Enterprise Value | 38.58B 403M 345M 322M 296M 555M 566M 3.82B 1.49B 19.34B 1.51B 1.48B 64.02B | EV / Sales 2025 |
2.49x | EV / Sales 2026 | 1.03x |
| Free-Float |
28.74% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | +1.25% | ||
| 1 week | -4.44% | ||
| Current month | +0.83% | ||
| 1 month | -12.18% | ||
| 3 months | +39.09% | ||
| 6 months | +40.90% | ||
| Current year | +17.39% |
| 1 week | 510 |  | 552.7 |
| 1 month | 485 | | 598.85 |
| Current year | 280 | | 685.95 |
| 1 year | 280 | | 685.95 |
| 3 years | 280 | | 949.85 |
| 5 years | 197.5 | | 949.85 |
| 10 years | 75.1 | | 949.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 09/08/2023 | |
Sanjay Jain
DFI | Director of Finance/CFO | - | 07/08/2024 |
Dhananjay Sathe
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 21/08/1977 | |
Pranay Godha
BRD | Director/Board Member | 53 | 09/08/2023 |
| Director/Board Member | 57 | 09/08/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.25% | -4.44% | +1.64% | +27.66% | 377M | |
| -1.40% | +4.30% | +78.76% | +129.25% | 1,141B | |
| -1.15% | +3.16% | +51.18% | +61.56% | 659B | |
| -0.46% | +5.45% | +26.46% | +76.15% | 470B | |
| +1.20% | +2.62% | +41.69% | +46.21% | 366B | |
| -0.61% | +2.10% | +23.43% | +40.38% | 302B | |
| +0.32% | +3.25% | +0.94% | +13.25% | 254B | |
| -1.71% | +4.06% | +46.67% | +66.78% | 239B | |
| -1.10% | -0.70% | -14.31% | -53.04% | 207B | |
| -1.59% | +5.15% | +22.34% | +91.28% | 183B | |
| Average | -0.55% | +3.13% | +27.88% | +49.95% | 382.14B | |
| Weighted average by Cap. | -0.84% | +4.31% | +44.72% | +72.76% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 21.11B 221M 189M 176M 162M 304M 310M 2.09B 815M 10.58B 828M 810M 35.02B | 22.02B 230M 197M 184M 169M 317M 323M 2.18B 850M 11.03B 864M 845M 36.53B |
| Net income | 1.38B 14.37M 12.31M 11.48M 10.54M 19.8M 20.19M 136M 53.1M 689M 53.96M 52.79M 2.28B | 2.53B 26.42M 22.62M 21.11M 19.37M 36.4M 37.11M 250M 97.62M 1.27B 99.22M 97.06M 4.2B |
| Net Debt | 3.7B 38.69M 33.13M 30.91M 28.36M 53.29M 54.34M 367M 143M 1.86B 145M 142M 6.14B | 2.11B 22.02M 18.85M 17.59M 16.14M 30.33M 30.92M 209M 81.34M 1.06B 82.67M 80.87M 3.5B |
Employees
2,780
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/08/26 | ₹518.10 | +1.25% | 2,646 |
| 19/08/26 | ₹511.70 | -3.55% | 6,960 |
| 18/08/26 | ₹530.55 | -2.25% | 7,301 |
| 17/08/26 | ₹542.75 | +0.73% | 4,428 |
| 14/08/26 | ₹538.80 | -1.07% | 10,570 |
- Stock Market
- Stocks
- UNICHEMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
